Wuhan General Group (China), Inc. (WUHN)

OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0001 (25.00%)
At close: Mar 3, 2026
150.00%
Market Cap 27.58K
Revenue (ttm) 80.38M
Net Income (ttm) -11.32M
Shares Out 55.15M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 26,196
Open 0.0005
Previous Close 0.0004
Day's Range 0.0005 - 0.0005
52-Week Range 0.0000 - 0.0005
Beta -3.55
RSI 63.60
Earnings Date n/a

About WUHN

Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada. [Read more]

Sector Healthcare
CEO Jeffrey Robinson
Employees 700
Stock Exchange OTCMKTS
Ticker Symbol WUHN
Full Company Profile

Financial Performance

In 2012, WUHN's revenue was $80.38 million, a decrease of -36.96% compared to the previous year's $127.50 million. Losses were -$11.32 million, 146.8% more than in 2011.

Financial Statements

News

There is no news available yet.